ACell, Inc.

United States of America

Back to Profile

1-67 of 67 for ACell, Inc. Sort by
Query
Aggregations
IP Type
        Patent 38
        Trademark 29
Jurisdiction
        United States 37
        Europe 11
        Canada 11
        World 8
Date
2024 2
2023 2
2022 4
2021 1
Before 2021 58
IPC Class
A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof 29
A61L 27/54 - Biologically active materials, e.g. therapeutic substances 14
A61K 35/12 - Materials from mammalsCompositions comprising non-specified tissues or cellsCompositions comprising non-embryonic stem cellsGenetically modified cells 13
A61L 27/58 - Materials at least partially resorbable by the body 13
A61L 27/50 - Materials characterised by their function or physical properties 11
See more
NICE Class
05 - Pharmaceutical, veterinary and sanitary products 28
10 - Medical apparatus and instruments 26
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services 2
Status
Pending 2
Registered / In Force 65

1.

Porous Foams Derived From Extracellular Matrix, Porous Foam ECM Medical Devices, and Methods of Use and Making Thereof

      
Application Number 18660108
Status Pending
Filing Date 2024-05-09
First Publication Date 2024-10-17
Owner ACell, Inc. (USA)
Inventor
  • Valmikinathan, Chandra M.
  • Gheewala, Nikhil Niraj
  • Young, Brent Donald
  • Gilbert, Thomas Wayne

Abstract

The invention disclosed herein is directed to a porous wound healing foam composition that is made from an extracellular matrix of a mammal, method of making, and method of using.

IPC Classes  ?

  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/56 - Porous or cellular materials
  • B33Y 10/00 - Processes of additive manufacturing
  • B33Y 70/00 - Materials specially adapted for additive manufacturing
  • B33Y 80/00 - Products made by additive manufacturing

2.

Medical Graft Devices And Methods Of Making Thereof

      
Application Number 18259461
Status Pending
Filing Date 2021-12-17
First Publication Date 2024-09-26
Owner ACell, Inc. (USA)
Inventor
  • Marks, Andrea S.
  • Remlinger, Nathaniel
  • Lebrun, Alexander M.

Abstract

Large-area medical graft devices comprise at least two sheets of extracellular matrix material (ECM). The sheets of ECM have overlapping regions that are compressed together during a non-drying process, and other overlapping regions that are not compressed together. The compressed overlapping regions have a more collapsed matrix structure, while the non-compressed overlapping regions having a more open matrix structure. The sheets of ECM can have a stacked orientation to create a desired thickness, or a staggered orientation to create a desired surface area, or combinations of both orientations.

IPC Classes  ?

  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61K 35/38 - StomachIntestineGoblet cellsOral mucosaSaliva
  • A61L 27/56 - Porous or cellular materials

3.

CARDION

      
Serial Number 98303963
Status Registered
Filing Date 2023-12-07
Registration Date 2024-11-05
Owner ACell, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Scaffold composed of biologically-derived tissue, tissue matter and tissue matrix for management, repair, reconstruction, and restoration of tissues; scaffold composed of biologically-derived tissue matrix for the management, repair, reconstruction and restoration of tissue in a patient

4.

Extracellular matrix sheet devices with improved mechanical properties and method of making

      
Application Number 17554105
Grant Number 11826490
Status In Force
Filing Date 2021-12-17
First Publication Date 2023-11-28
Grant Date 2023-11-28
Owner ACell, Inc. (USA)
Inventor
  • Remlinger, Nathaniel
  • Huleihel, Luai
  • Tang, Jiayu

Abstract

Described are devices and associated methods of producing extracellular matrix (ECM) sheet devices with strengthened mechanical properties due to the selective retention of muscle tissue layers during processing.

IPC Classes  ?

  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61K 9/70 - Web, sheet or filament bases
  • A61K 35/12 - Materials from mammalsCompositions comprising non-specified tissues or cellsCompositions comprising non-embryonic stem cellsGenetically modified cells
  • A61K 35/34 - MusclesSmooth muscle cellsHeartCardiac stem cellsMyoblastsMyocytesCardiomyocytes

5.

MEDICAL GRAFT DEVICES AND METHODS OF MAKING THEREOF

      
Application Number US2021064119
Publication Number 2022/146725
Status In Force
Filing Date 2021-12-17
Publication Date 2022-07-07
Owner ACELL, INC. (USA)
Inventor
  • Marks, Andrea, S.
  • Remlinger, Nathaniel
  • Lebrun, Alexander, M.

Abstract

Large-area medical graft devices comprise at least two sheets of extracellular matrix material (ECM). The sheets of ECM have overlapping regions that are compressed together during a non-drying process, and other overlapping regions that are not compressed together. The compressed overlapping regions have a more collapsed matrix structure, while the non-compressed overlapping regions having a more open matrix structure. The sheets of ECM can have a stacked orientation to create a desired thickness, or a staggered orientation to create a desired surface area, or combinations of both orientations.

IPC Classes  ?

  • A61L 15/32 - Proteins, polypeptidesDegradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
  • A61L 26/00 - Chemical aspects of, or use of materials for, liquid bandages
  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • B32B 27/04 - Layered products essentially comprising synthetic resin as impregnant, bonding, or embedding substance
  • B32B 7/05 - Interconnection of layers the layers not being connected over the whole surface, e.g. discontinuous connection or patterned connection
  • B32B 9/02 - Layered products essentially comprising a particular substance not covered by groups comprising animal or vegetable substances

6.

IMPLANTABLE POUCH DEVICE AND METHODS OF MAKING THEREOF

      
Application Number US2021064227
Publication Number 2022/146730
Status In Force
Filing Date 2021-12-17
Publication Date 2022-07-07
Owner ACELL, INC. (USA)
Inventor
  • Remlinger, Nathaniel
  • Gilbert, Thomas, W.
  • Marks, Andrea, S.
  • Young, D., Adam
  • Huleihel, Luai
  • Reisher, Nichol
  • Tang, Jiayu

Abstract

Implantable pouch devices for encasing a cardiac implantable electronic device (CIED) or other medical device are formed from one or more bioresorbable sheets of material comprising an extracellular matrix (ECM) for maintaining and supporting a healing environment. Each bioresorbable sheet may be a medical graft assembly which comprises at least first and second sheets of ECM material layered together such that the epithelial basement membrane sides face outward.

IPC Classes  ?

  • A61L 31/00 - Materials for other surgical articles
  • A61M 60/00 - Blood pumpsDevices for mechanical circulatory actuationBalloon pumps for circulatory assistance

7.

MICROMATRIX FLEX

      
Application Number 018718266
Status Registered
Filing Date 2022-06-16
Registration Date 2022-10-26
Owner ACell, Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

Scaffold composed of biological tissue in powdered form for medical use; naturally occurring bio-scaffold in powdered form for repair or restoration of tissue in a patient; wound dressings; medical dressings, coverings and applicators; pre-filled syringes for medical purposes. Scaffold composed of non-living material in powdered form for repair or restoration of tissue in a patient; medical devices for treating wounds; scaffold composed of non-living material in powdered form for applying to a wound in a syringe with a flexible tip; disposable syringes; injection syringes; medical syringes; parts and fitting for syringes.

8.

MICROMATRIX FLEX

      
Serial Number 97457756
Status Registered
Filing Date 2022-06-14
Registration Date 2024-04-16
Owner ACell, Inc. ()
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

Scaffold composed of biological tissue in powdered form for medical use; naturally occurring bio-scaffold in powdered form for repair or restoration of tissue in a patient; wound dressings Scaffold composed of non-living material in powdered form for repair or restoration of tissue in a patient; medical devices for treating wounds; scaffold composed of non-living material in powdered form for applying to a wound in a syringe with a flexible tip

9.

Porous foams derived from extracellular matrix, porous foam ECM medical devices, and methods of use and making thereof

      
Application Number 17105780
Grant Number 11992579
Status In Force
Filing Date 2020-11-27
First Publication Date 2021-03-18
Grant Date 2024-05-28
Owner ACell, Inc. (USA)
Inventor
  • Valmikinathan, Chandra M.
  • Gheewala, Nikhil Niraj
  • Young, Brent Donald
  • Gilbert, Thomas Wayne

Abstract

The invention disclosed herein is directed to a porous wound healing foam composition that is made from an extracellular matrix of a mammal, method of making, and method of using.

IPC Classes  ?

  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/56 - Porous or cellular materials
  • B33Y 70/00 - Materials specially adapted for additive manufacturing
  • B33Y 10/00 - Processes of additive manufacturing
  • B33Y 80/00 - Products made by additive manufacturing

10.

CARDION

      
Application Number 203689400
Status Registered
Filing Date 2020-06-29
Registration Date 2025-06-13
Owner ACell, Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

(1) Scaffold composed of biologically-derived tissue, tissue matter and tissue matrix for management, repair, reconstruction, and restoration of tissues; scaffold composed of biologically-derived tissue matrix for the management, repair, reconstruction and restoration of tissue in a patient (2) Medical and surgical devices, namely, non-living extra cellular matter, matrix scaffold and implantable scaffolds comprised of natural, non-living materials for management, repair, reconstruction, and restoration of tissues

11.

CARDION

      
Application Number 018262923
Status Registered
Filing Date 2020-06-29
Registration Date 2020-12-15
Owner ACell, Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

Scaffold composed of biologically-derived tissue, tissue matter and tissue matrix for management, repair, reconstruction, and restoration of tissues; scaffold composed of biologically-derived tissue matrix for the management, repair, reconstruction and restoration of tissue in a patient. Medical and surgical devices, namely, non-living extra cellular matter, matrix scaffold and implantable scaffolds comprised of natural, non-living materials for management, repair, reconstruction, and restoration of tissues.

12.

Particulate tissue graft with components of differing density and methods of making and using the same

      
Application Number 16196272
Grant Number 11013829
Status In Force
Filing Date 2018-11-20
First Publication Date 2019-04-11
Grant Date 2021-05-25
Owner ACELL, INC. (USA)
Inventor
  • Bosley, Jr., Rodney W.
  • Fette, Clay
  • Tullius, Robert S.

Abstract

Disclosed are tissue graft compositions made of particles having different densities, methods of making these compositions, and methods of using these compositions for promoting tissue restoration in a patient.

IPC Classes  ?

  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/26 - Mixtures of macromolecular materials
  • A61L 27/28 - Materials for coating prostheses
  • A61K 35/12 - Materials from mammalsCompositions comprising non-specified tissues or cellsCompositions comprising non-embryonic stem cellsGenetically modified cells
  • A61K 9/14 - Particulate form, e.g. powders
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61L 27/40 - Composite materials, i.e. layered or containing one material dispersed in a matrix of the same or different material
  • A61L 27/50 - Materials characterised by their function or physical properties
  • A61L 27/54 - Biologically active materials, e.g. therapeutic substances
  • A61L 27/58 - Materials at least partially resorbable by the body

13.

Particulate tissue graft with components of differing density and methods of making and using the same

      
Application Number 16158805
Grant Number 10898610
Status In Force
Filing Date 2018-10-12
First Publication Date 2019-02-07
Grant Date 2021-01-26
Owner ACELL, INC. (USA)
Inventor
  • Bosley, Jr., Rodney W.
  • Fette, Clay
  • Tullius, Robert S.

Abstract

Disclosed are tissue graft compositions made of particles having different densities, methods of making these compositions, and methods of using these compositions for promoting tissue restoration in a patient.

IPC Classes  ?

  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/26 - Mixtures of macromolecular materials
  • A61L 27/58 - Materials at least partially resorbable by the body
  • A61K 35/12 - Materials from mammalsCompositions comprising non-specified tissues or cellsCompositions comprising non-embryonic stem cellsGenetically modified cells
  • A61K 9/14 - Particulate form, e.g. powders
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61L 27/40 - Composite materials, i.e. layered or containing one material dispersed in a matrix of the same or different material
  • A61L 27/50 - Materials characterised by their function or physical properties
  • A61L 27/54 - Biologically active materials, e.g. therapeutic substances

14.

MICROMATRIX

      
Application Number 017993059
Status Registered
Filing Date 2018-11-27
Registration Date 2019-04-20
Owner ACell, Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

Scaffold composed of biological tissue in powdered form for medical use; naturally occurring bio-scaffold in powdered form for repair or restoration of tissue in a patient. Scaffold composed of non-living material in powdered form for repair or restoration of tissue in a patient.

15.

EXTRACELLULAR MATRIX COMPOSITIONS WITH BACTERICIDAL OR BACTERIOSTATIC CHARACTERISTICS USEFUL FOR PROTECTING AND TREATING PATIENTS WITH BACTERIAL INFECTIONS

      
Application Number US2018024313
Publication Number 2018/183181
Status In Force
Filing Date 2018-03-26
Publication Date 2018-10-04
Owner
  • ACELL, INC. (USA)
  • UNIVERSITY OF PITTSBURGH (USA)
Inventor
  • Gilbert, Thomas Wayne
  • Di, Yuanpu

Abstract

Described is a formulation and method for reducing and treating bacterial infections in humans and animals with digested or non-digested extracellular matrix materials derived from non-epithelial and epithelial tissues.

IPC Classes  ?

  • A61K 35/22 - UrineUrinary tract, e.g. kidney or bladderIntraglomerular mesangial cellsRenal mesenchymal cellsAdrenal gland
  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/54 - Biologically active materials, e.g. therapeutic substances
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 35/37 - Digestive system
  • A61P 31/04 - Antibacterial agents
  • A61P 11/00 - Drugs for disorders of the respiratory system

16.

MICROMATRIX

      
Serial Number 87920031
Status Registered
Filing Date 2018-05-14
Registration Date 2019-05-07
Owner ACell, Inc. ()
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

Scaffold composed of biological tissue in powdered form for medical use; naturally occurring bio-scaffold in powdered form for repair or restoration of tissue in a patient Scaffold composed of non-living material in powdered form for repair or restoration of tissue in a patient

17.

MICROMATRIX

      
Application Number 189883100
Status Registered
Filing Date 2018-05-11
Registration Date 2022-08-18
Owner ACell, Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

(1) Scaffold composed of biological tissue in powdered form for medical use; naturally occurring bio-scaffold in powdered form for repair or restoration of tissue in a patient. (2) Scaffold composed of non-living material in powdered form for repair or restoration of tissue in a patient

18.

MATRISTEM URINARY BLADDER MATRIX

      
Application Number 189792100
Status Registered
Filing Date 2018-05-07
Registration Date 2021-06-17
Owner ACell, Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

(1) Wound dressings; surgical implants comprised of living tissues; Biological tissue cultures for medical and veterinary purposes, namely, implantable scaffold composed of biologically-derived tissue in the form of sheets, gels, foam and in powdered form, comprised of extra cellular matrix for repair and restoration of human and animal tissues; Biological tissue cultures for medical and veterinary purposes, namely, surgical implants comprising living tissues and biomaterials in the form of scaffolds for use in wound healing, surgery as well as for regeneration of tissue and organs; Biological tissue cultures for medical and veterinary purposes, namely, implants comprising biologically-derived extracellular tissue matrix in sheet, gels, foam, and powered form; Biological tissue cultures used as a surgical repair medium, namely, surgical implants comprising biologically-derived material for use in surgery and to repair and restore human and animal tissue (2) Surgical implants comprised of artificial materials; Prosthetic tissues for repair and restoration of human and animal tissues, namely, non-living extra-cellular matrix scaffold and implantable scaffold comprised of non-living extra cellular matter; Prosthetic tissues for repair and restoration of human and animal tissues, namely, surgical implants comprising non-living implant materials in the form of scaffolds and implantable sheets, gels, foam and in powdered form for use in wound healing, and surgery, and for regeneration of tissue and organs

19.

MATRISTEM UBM

      
Application Number 189792200
Status Registered
Filing Date 2018-05-07
Registration Date 2021-06-17
Owner ACell, Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

(1) Wound dressings; surgical implants comprised of living tissues; Biological tissue cultures for medical and veterinary purposes, namely, implantable scaffold composed of biologically-derived tissue in the form of sheets, gels, foam and in powdered form, comprised of extra cellular matrix for repair and restoration of human and animal tissues; Biological tissue cultures for medical and veterinary purposes, namely, surgical implants comprising living tissues and biomaterials in the form of scaffolds for use in wound healing, surgery as well as for regeneration of tissue and organs; Biological tissue cultures for medical and veterinary purposes, namely, implants comprising biologically-derived extracellular tissue matrix in sheet, gels, foam, and powered form; Biological tissue cultures used as a surgical repair medium, namely, surgical implants comprising biologically-derived material for use in surgery and to repair and restore human and animal tissue (2) Surgical implants comprised of artificial materials; Prosthetic tissues for repair and restoration of human and animal tissues, namely, non-living extra-cellular matrix scaffold and implantable scaffold comprised of non-living extra cellular matter; Prosthetic tissues for repair and restoration of human and animal tissues, namely, surgical implants comprising non-living implant materials in the form of scaffolds and implantable sheets, gels, foam and in powdered form for use in wound healing, and surgery, and for regeneration of tissue and organs

20.

GENTRIX

      
Application Number 189792700
Status Registered
Filing Date 2018-05-07
Registration Date 2021-07-23
Owner ACell, Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

(1) Wound dressings; surgical implants comprised of living tissues; Biological tissue cultures for medical and veterinary purposes, namely, implantable scaffold composed of biologically-derived tissue in the form of sheets, gels, foam and in powdered form, comprised of extra cellular matrix for repair and restoration of human and animal tissues; Biological tissue cultures for medical and veterinary purposes, namely, surgical implants comprising living tissues and biomaterials in the form of scaffolds for use in wound healing, surgery as well as for regeneration of tissue and organs; Biological tissue cultures for medical and veterinary purposes, namely, implants comprising biologically-derived extracellular tissue matrix in sheet, gels, foam, and powered form; Biological tissue cultures used as a surgical repair medium, namely, surgical implants comprising biologically-derived material for use in surgery and to repair and restore human and animal tissue (2) Surgical implants comprised of artificial materials; Prosthetic tissues for repair and restoration of human and animal tissues, namely, non-living extra-cellular matrix scaffold and implantable scaffold comprised of non-living extra cellular matter; Prosthetic tissues for repair and restoration of human and animal tissues, namely, surgical implants comprising non-living implant materials in the form of scaffolds and implantable sheets, gels, foam and in powdered form for use in wound healing, and surgery, and for regeneration of tissue and organs

21.

GENTRIX

      
Application Number 017510926
Status Registered
Filing Date 2017-11-22
Registration Date 2018-03-22
Owner Acell, Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

materials for dressings; surgical implants comprised of living tissues; Implantable scaffold composed of biologically-derived tissue in the form of sheets of extra cellular matrix for repair and restoration of human and animal tissues; surgical implants comprising living tissues and biomaterials in the form of scaffolds for use in wound healing, surgery as well as for regeneration of tissue and organs; medical preparations for the regeneration of tissue; implants comprising biologically-derived extracellular tissue matrix in the form of implantable sheets; Surgical repair medium, namely, surgical implants comprising biologically-derived material for use in surgery and to repair and restore human and animal tissue. Surgical apparatus and instruments; Medical and veterinary apparatus and instruments; therapeutic and prosthetic articles and devices for implantation composed of artificial or synthetic materials; surgical implants comprised of artificial materials; Implantable scaffold comprised of non-living extra cellular matter for repair and restoration of human and animal tissues; implantable scaffold composed of non-living implant materials for repair or restoration of tissue; surgical implants comprising non-living implant materials in the form of scaffolds and implantable sheets for use in wound healing, and surgery, as well as for regeneration of tissue and organs; Surgical and wound treating equipment.

22.

GENTRIX SURGICAL MATRIX EXTEND

      
Application Number 017510942
Status Registered
Filing Date 2017-11-22
Registration Date 2018-03-22
Owner Acell, Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

materials for dressings; surgical implants comprised of living tissues; Implantable scaffold composed of biologically-derived tissue in the form of sheets of extra cellular matrix for repair and restoration of human and animal tissues; surgical implants comprising living tissues and biomaterials in the form of scaffolds for use in wound healing, surgery as well as for regeneration of tissue and organs; medical preparations for the regeneration of tissue; implants comprising biologically-derived extracellular tissue matrix in the form of implantable sheets; Surgical repair medium, namely, surgical implants comprising biologically-derived material for use in surgery and to repair and restore human and animal tissue. Surgical apparatus and instruments; Medical, and veterinary apparatus and instruments; therapeutic and prosthetic articles and devices for implantation composed of artificial or synthetic materials; surgical implants comprised of artificial materials; Implantable scaffold comprised of non-living extra cellular matter for repair and restoration of human and animal tissues; implantable scaffold composed of non-living implant materials for repair or restoration of tissue; surgical implants comprising non-living implant materials in the form of scaffolds and implantable sheets for use in wound healing, and surgery, as well as for regeneration of tissue and organs; surgical and wound treating equipment.

23.

MATRISTEM UBM

      
Application Number 017510959
Status Registered
Filing Date 2017-11-22
Registration Date 2018-03-22
Owner Acell, Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceuticals; Medical preparations; Veterinary preparations; sanitary preparations for medical purposes; materials for dressings; surgical implants comprised of living tissues; Scaffold composed of biologically-derived tissue for management, repair and restoration of tissues; scaffold composed of biologically-derived tissue for the management of wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunnel/undermined wounds, surgical wounds, trauma wounds, burns, skin tears, abrasions, and lacerations; scaffold composed of biological tissue, in the form of sheets, gels, foam and in powdered form, comprised of extracellular matrix for repair and restoration of human and animal tissues; surgical implants comprising living tissues and biomaterials in the form of scaffolds and scaffold material in sheet, gels, foam, and powered form for use in wound healing, surgery as well as for constructive remodeling or regeneration of tissue and organs; medical preparations for the constructive remodeling or regeneration of tissue; implants comprising extracellular tissue matrix in the form of implantable sheets, gels, foam and powder; Surgical repair medium, namely, surgical implants comprising biological material for use in surgery and to repair and restore human and animal tissue. Surgical apparatus and instruments; Medical, and veterinary apparatus and instruments; therapeutic and prosthetic articles and devices for implantation composed of artificial or synthetic materials; surgical implants comprised of artificial materials; Medical devices, namely, non-living extracellular matrix scaffold and implantable scaffolds comprised of natural, non-living materials for management, repair and restoration of tissues; medical devices, namely, non-living extracellular matrix scaffold and implantable scaffolds all comprised of natural, non-living materials for repair and restoration of tissue; medical devices, namely, non-living extracellular matrix scaffold and implantable scaffolds comprised of natural, non-living materials for repair and restoration of tissue, namely, for the management of wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunnel/undermined wounds, surgical wounds, trauma wounds, burns, skin tears, abrasions, and lacerations; scaffold comprised of non-living extracellular matter in the form of sheets, gels, foam and in powdered form for repair and restoration of human and animal tissues; Scaffold composed of non-living implants for repair or restoration of tissue; surgical implants comprising non-living implants in the form of scaffolds, implantable sheets, gels, foam and in powdered form for use in wound healing, and surgery, as well as for constructive remodeling or regeneration of tissue and organs; surgical and wound treating equipment.

24.

MATRISTEM URINARY BLADDER MATRIX

      
Application Number 017510975
Status Registered
Filing Date 2017-11-22
Registration Date 2018-03-22
Owner Acell, Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceuticals; Medical preparations; Veterinary preparations; sanitary preparations for medical purposes; materials for dressings; surgical implants comprised of living tissues; Scaffold composed of biologically-derived tissue for management, repair and restoration of tissues; scaffold composed of biologically-derived tissue for the management of wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunnel/undermined wounds, surgical wounds, trauma wounds, burns, skin tears, abrasions, and lacerations; scaffold composed of biological tissue, in the form of sheets, gels, foam and in powdered form, comprised of extracellular matrix for repair and restoration of human and animal tissues; surgical implants comprising living tissues and biomaterials in the form of scaffolds and scaffold material in sheet, gels, foam, and powered form for use in wound healing, surgery as well as for constructive remodeling or regeneration of tissue and organs; medical preparations for the constructive remodeling or regeneration of tissue; implants comprising extracellular tissue matrix in the form of implantable sheets, gels, foam and powder; Surgical repair medium, namely, surgical implants comprising biological material for use in surgery and to repair and restore human and animal tissue. Surgical apparatus and instruments; Medical, and veterinary apparatus and instruments; therapeutic and prosthetic articles and devices for implantation composed of artificial or synthetic materials; surgical implants comprised of artificial materials; Medical devices, namely, non-living extracellular matrix scaffold and implantable scaffolds comprised of natural, non-living materials for management, repair and restoration of tissues; medical devices, namely, non-living extracellular matrix scaffold and implantable scaffolds all comprised of natural, non-living materials for repair and restoration of tissue; medical devices, namely, non-living extracellular matrix scaffold and implantable scaffolds comprised of natural, non-living materials for repair and restoration of tissue, namely, for the management of wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunnel/undermined wounds, surgical wounds, trauma wounds, burns, skin tears, abrasions, and lacerations; scaffold comprised of non-living extracellular matter in the form of sheets, gels, foam and in powdered form for repair and restoration of human and animal tissues; Scaffold composed of non-living implants for repair or restoration of tissue; surgical implants comprising non-living implants in the form of scaffolds, implantable sheets, gels, foam and in powdered form for use in wound healing, and surgery, as well as for constructive remodeling or regeneration of tissue and organs; surgical and wound treating equipment.

25.

Variable density tissue graft composition and methods of making and using the same

      
Application Number 15423813
Grant Number 10517994
Status In Force
Filing Date 2017-02-03
First Publication Date 2017-06-15
Grant Date 2019-12-31
Owner ACell, Inc. (USA)
Inventor
  • Bosley, Jr., Rodney W.
  • Fette, Clay

Abstract

Disclosed are tissue graft compositions made of materials having different densities, methods of making, and methods of treatment for restoring tissues in a patient.

IPC Classes  ?

  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/50 - Materials characterised by their function or physical properties
  • A61F 2/02 - Prostheses implantable into the body

26.

Particulate tissue graft with components of differing density and methods of making and using the same

      
Application Number 15354236
Grant Number 11000628
Status In Force
Filing Date 2016-11-17
First Publication Date 2017-04-27
Grant Date 2021-05-11
Owner ACELL, INC. (USA)
Inventor
  • Bosley, Jr., Rodney W.
  • Fette, Clay
  • Tullius, Robert S.

Abstract

Disclosed are tissue graft compositions made of particles having different densities, methods of making these compositions, and methods of using these compositions for promoting tissue restoration in a patient.

IPC Classes  ?

  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/26 - Mixtures of macromolecular materials
  • A61L 27/58 - Materials at least partially resorbable by the body
  • A61K 35/12 - Materials from mammalsCompositions comprising non-specified tissues or cellsCompositions comprising non-embryonic stem cellsGenetically modified cells
  • A61K 9/14 - Particulate form, e.g. powders
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61L 27/40 - Composite materials, i.e. layered or containing one material dispersed in a matrix of the same or different material
  • A61L 27/50 - Materials characterised by their function or physical properties
  • A61L 27/54 - Biologically active materials, e.g. therapeutic substances

27.

Hemostatic device

      
Application Number 15283702
Grant Number 09764056
Status In Force
Filing Date 2016-10-03
First Publication Date 2017-03-16
Grant Date 2017-09-19
Owner ACell, Inc. (USA)
Inventor
  • Fette, Clay
  • Janis, Abram
  • Kibalo, Benjamin

Abstract

A hemostatic device, method of making, and method of using for internal and external applications to wounds in the body of a patient to induce homeostasis at an anatomical site.

IPC Classes  ?

  • C12N 5/00 - Undifferentiated human, animal or plant cells, e.g. cell linesTissuesCultivation or maintenance thereofCulture media therefor
  • C12N 5/02 - Propagation of single cells or cells in suspensionMaintenance thereofCulture media therefor
  • A01N 63/00 - Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
  • A01N 65/00 - Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
  • A61F 2/00 - Filters implantable into blood vesselsProstheses, i.e. artificial substitutes or replacements for parts of the bodyAppliances for connecting them with the bodyDevices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
  • A61K 9/14 - Particulate form, e.g. powders
  • A61B 17/08 - Wound clamps
  • A61D 1/00 - Surgical instruments for veterinary use
  • A61L 24/00 - Surgical adhesives or cementsAdhesives for colostomy devices
  • A61B 17/00 - Surgical instruments, devices or methods
  • A61L 31/00 - Materials for other surgical articles
  • A61L 15/40 - Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/54 - Biologically active materials, e.g. therapeutic substances
  • A61L 27/58 - Materials at least partially resorbable by the body

28.

Methods of manufacturing bioactive gels from extracellular matrix material

      
Application Number 15290445
Grant Number 09795713
Status In Force
Filing Date 2016-10-11
First Publication Date 2017-02-16
Grant Date 2017-10-24
Owner ACell, Inc. (USA)
Inventor
  • Kentner, Kimberly
  • Stuart, Katherine A.
  • Janis, Abram D.

Abstract

The present invention is directed to methods of manufacturing bioactive gels from ECM material, i.e., gels which retain bioactivity, and can serve as scaffolds for preclinical and clinical tissue engineering and regenerative medicine approaches to tissue reconstruction. The manufacturing methods take advantage of a new recognition that bioactive gels from ECM material can be created by digesting particularized ECM material in an alkaline environment and neutralizing to provide bioactive gels.

IPC Classes  ?

  • C12N 5/00 - Undifferentiated human, animal or plant cells, e.g. cell linesTissuesCultivation or maintenance thereofCulture media therefor
  • C12N 5/02 - Propagation of single cells or cells in suspensionMaintenance thereofCulture media therefor
  • A61K 35/37 - Digestive system
  • A61K 35/38 - StomachIntestineGoblet cellsOral mucosaSaliva
  • A61K 35/407 - LiverHepatocytes
  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/52 - Hydrogels or hydrocolloids
  • A61L 27/54 - Biologically active materials, e.g. therapeutic substances
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 35/22 - UrineUrinary tract, e.g. kidney or bladderIntraglomerular mesangial cellsRenal mesenchymal cellsAdrenal gland
  • A61K 35/12 - Materials from mammalsCompositions comprising non-specified tissues or cellsCompositions comprising non-embryonic stem cellsGenetically modified cells
  • A61K 38/18 - Growth factorsGrowth regulators
  • A61L 27/50 - Materials characterised by their function or physical properties
  • A61L 27/22 - Polypeptides or derivatives thereof

29.

Methods of manufacturing bioactive gels from extracellular matrix material

      
Application Number 14969800
Grant Number 09474829
Status In Force
Filing Date 2015-12-15
First Publication Date 2016-05-12
Grant Date 2016-10-25
Owner ACell, Inc. (USA)
Inventor
  • Kentner, Kimberly A.
  • Stuart, Katherine A.
  • Janis, Abram D.

Abstract

The present invention is directed to methods of manufacturing bioactive gels from ECM material, i.e., gels which retain bioactivity, and can serve as scaffolds for preclinical and clinical tissue engineering and regenerative medicine approaches to tissue reconstruction. The manufacturing methods take advantage of a new recognition that bioactive gels from ECM material can be created by digesting particularized ECM material in an alkaline environment and neutralizing to provide bioactive gels.

IPC Classes  ?

  • C12N 5/00 - Undifferentiated human, animal or plant cells, e.g. cell linesTissuesCultivation or maintenance thereofCulture media therefor
  • C12N 5/02 - Propagation of single cells or cells in suspensionMaintenance thereofCulture media therefor
  • A61K 35/37 - Digestive system
  • A61K 35/38 - StomachIntestineGoblet cellsOral mucosaSaliva
  • A61K 35/407 - LiverHepatocytes
  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/52 - Hydrogels or hydrocolloids
  • A61L 27/54 - Biologically active materials, e.g. therapeutic substances
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 35/22 - UrineUrinary tract, e.g. kidney or bladderIntraglomerular mesangial cellsRenal mesenchymal cellsAdrenal gland
  • A61K 35/12 - Materials from mammalsCompositions comprising non-specified tissues or cellsCompositions comprising non-embryonic stem cellsGenetically modified cells
  • A61K 38/18 - Growth factorsGrowth regulators
  • A61L 27/50 - Materials characterised by their function or physical properties
  • A61L 27/22 - Polypeptides or derivatives thereof

30.

CYTAL

      
Application Number 015316938
Status Registered
Filing Date 2016-04-08
Registration Date 2016-08-12
Owner Acell, Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

extra cellular matrix scaffold; scaffold composed of biologically-derived tissue matrix for management, repair and restoration of tissues; scaffold composed of biologically-derived tissue matrix for the management of wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunnel/undermined wounds, surgical wounds, trauma wounds, burns, skin tears, abrasions, and lacerations; Wound dressings; Materials for dressing wounds. Medical devices, namely, non-living extra cellular matrix scaffold and implantable scaffolds; medical devices, namely, non-living extra cellular matrix scaffold and implantable scaffolds all comprised of natural, non-living materials for repair and restoration of tissue; medical devices, namely, non-living extra cellular matrix scaffold and implantable scaffolds comprised of natural, non-living materials for repair and restoration of tissue, namely, for the management of wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunnel/undermined wounds, surgical wounds, trauma wounds, burns, skin tears, abrasions, and lacerations; Suture and wound closing materials and products.

31.

CYTAL

      
Application Number 177620200
Status Registered
Filing Date 2016-04-07
Registration Date 2019-01-10
Owner ACell, Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

(1) Extra cellular matrix scaffold; scaffold composed of biologically-derived tissue matrix for management, repair and restoration of tissues; scaffold composed of biologically-derived tissue matrix for the management of wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunnel/undermined wounds, surgical wounds, trauma wounds, burns, skin tears, abrasions, and lacerations (2) Medical devices, namely, non-living extra cellular matrix scaffold and implantable scaffolds; medical devices, namely, non-living extra cellular matrix scaffold and implantable scaffolds all comprised of natural, non-living materials for repair and restoration of tissue; medical devices, namely, non-living extra cellular matrix scaffold and implantable scaffolds comprised of natural, non-living materials for repair and restoration of tissue, namely, for the management of wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunnel/undermined wounds, surgical wounds, trauma wounds, burns, skin tears, abrasions, and lacerations

32.

Hemostatic device

      
Application Number 14969060
Grant Number 09480771
Status In Force
Filing Date 2015-12-15
First Publication Date 2016-04-07
Grant Date 2016-11-01
Owner ACell, Inc. (USA)
Inventor
  • Fette, Clay
  • Janis, Abram
  • Kibalo, Benjamin

Abstract

A hemostatic device, method of making, and method of using for internal and external applications to wounds in the body of a patient to induce hemostasis at an anatomical site.

IPC Classes  ?

  • C12N 5/00 - Undifferentiated human, animal or plant cells, e.g. cell linesTissuesCultivation or maintenance thereofCulture media therefor
  • C12N 5/02 - Propagation of single cells or cells in suspensionMaintenance thereofCulture media therefor
  • A01N 63/00 - Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
  • A01N 65/00 - Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
  • A61F 2/00 - Filters implantable into blood vesselsProstheses, i.e. artificial substitutes or replacements for parts of the bodyAppliances for connecting them with the bodyDevices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
  • A61K 9/14 - Particulate form, e.g. powders
  • A61B 17/08 - Wound clamps
  • A61D 1/00 - Surgical instruments for veterinary use
  • A61L 24/00 - Surgical adhesives or cementsAdhesives for colostomy devices
  • A61B 17/00 - Surgical instruments, devices or methods
  • A61L 31/00 - Materials for other surgical articles
  • A61L 15/40 - Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/54 - Biologically active materials, e.g. therapeutic substances
  • A61L 27/58 - Materials at least partially resorbable by the body

33.

POROUS FOAMS DERIVED FROM EXTRACELLULAR MATRIX, POROUS FOAM ECM MEDICAL DEVICES, AND METHODS OF USE AND MAKING THEREOF

      
Document Number 02962203
Status In Force
Filing Date 2015-09-22
Open to Public Date 2016-03-31
Grant Date 2020-04-28
Owner ACELL, INC. (USA)
Inventor
  • Valmikinathan, Chandra M.
  • Gheewala, Nikhil N.
  • Young, Brent D.
  • Gilbert, Thomas W.

Abstract

The invention disclosed herein is directed to a porous wound healing foam composition that is made from an extracellular matrix of a mammal, method of making, and method of using.

IPC Classes  ?

  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/56 - Porous or cellular materials
  • B29C 64/10 - Processes of additive manufacturing

34.

POROUS FOAMS DERIVED FROM EXTRACELLULAR MATRIX, POROUS FOAM ECM MEDICAL DEVICES, AND METHODS OF USE AND MAKING THEREOF

      
Application Number US2015051328
Publication Number 2016/048946
Status In Force
Filing Date 2015-09-22
Publication Date 2016-03-31
Owner ACELL, INC. (USA)
Inventor
  • Valmikinathan, Chandra, M.
  • Gheewala, Nikhil, N.
  • Young, Brent, D.
  • Gilbert, Thomas, W.

Abstract

The invention disclosed herein is directed to a porous wound healing foam composition that is made from an extracellular matrix of a mammal, method of making, and method of using.

IPC Classes  ?

  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/56 - Porous or cellular materials

35.

GENTRIX

      
Serial Number 86956739
Status Registered
Filing Date 2016-03-29
Registration Date 2017-09-26
Owner ACell, Inc. ()
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

Implantable scaffold composed of biologically-derived tissue in the form of sheets of extra cellular matrix for repair and restoration of human and animal tissues; surgical implants comprising living tissues and biomaterials in the form of scaffolds for use in wound healing, surgery as well as for regeneration of tissue and organs; medical preparations for the regeneration of tissue; implants comprising biologically-derived extracellular tissue matrix in the form of implantable sheets; Surgical repair medium, namely, surgical implants comprising biologically-derived material for use in surgery and to repair and restore human and animal tissue Implantable scaffold comprised of non-living extra cellular matter for repair and restoration of human and animal tissues; implantable scaffold composed of non-living implant materials for repair or restoration of tissue; surgical implants comprising non-living implant materials in the form of scaffolds and implantable sheets for use in wound healing, and surgery, as well as for regeneration of tissue and organs

36.

Methods of manufacturing bioactive gels from extracellular matrix material

      
Application Number 14811993
Grant Number 09238091
Status In Force
Filing Date 2015-07-29
First Publication Date 2015-11-26
Grant Date 2016-01-19
Owner ACell, Inc. (USA)
Inventor
  • Kentner, Kimberly A.
  • Stuart, Katherine A.
  • Janis, Abram D.

Abstract

The present invention is directed to methods of manufacturing bioactive gels from ECM material, i.e., gels which retain bioactivity, and can serve as scaffolds for preclinical and clinical tissue engineering and regenerative medicine approaches to tissue reconstruction. The manufacturing methods take advantage of a new recognition that bioactive gels from ECM material can be created by digesting particularized ECM material in an alkaline environment and neutralizing to provide bioactive gels.

IPC Classes  ?

  • C12N 5/00 - Undifferentiated human, animal or plant cells, e.g. cell linesTissuesCultivation or maintenance thereofCulture media therefor
  • C12N 5/02 - Propagation of single cells or cells in suspensionMaintenance thereofCulture media therefor
  • A61K 35/37 - Digestive system
  • A61K 35/38 - StomachIntestineGoblet cellsOral mucosaSaliva
  • A61K 35/407 - LiverHepatocytes
  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/50 - Materials characterised by their function or physical properties
  • A61L 27/54 - Biologically active materials, e.g. therapeutic substances
  • A61L 27/52 - Hydrogels or hydrocolloids

37.

CYTAL

      
Serial Number 86783355
Status Registered
Filing Date 2015-10-09
Registration Date 2017-05-02
Owner ACell, Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

Scaffold composed of biologically-derived tissue matrix for management, repair and restoration of tissues; scaffold composed of biologically-derived tissue matrix for the management of wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunnel/undermined wounds, surgical wounds, trauma wounds, burns, skin tears, abrasions, and lacerations Medical devices, namely, non-living extra cellular matrix scaffold and implantable scaffolds comprised of natural, non-living materials for management, repair and restoration of tissues; medical devices, namely, non-living extra cellular matrix scaffold and implantable scaffolds all comprised of natural, non-living materials for repair and restoration of tissue; medical devices, namely, non-living extra cellular matrix scaffold and implantable scaffolds comprised of natural, non-living materials for repair and restoration of tissue, namely, for the management of wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunnel/undermined wounds, surgical wounds, trauma wounds, burns, skin tears, abrasions, and lacerations

38.

Particulate tissue graft with components of differing density and methods of making and using the same

      
Application Number 14712084
Grant Number 09561307
Status In Force
Filing Date 2015-05-14
First Publication Date 2015-09-24
Grant Date 2017-02-07
Owner ACell, Inc. (USA)
Inventor
  • Bosley, Jr., Rodney W.
  • Fette, Clay
  • Tullius, Robert S.

Abstract

Disclosed are tissue graft compositions made of particles having different densities, methods of making these compositions, and methods of using these compositions for promoting tissue restoration in a patient.

IPC Classes  ?

  • A61L 27/58 - Materials at least partially resorbable by the body
  • A61L 27/50 - Materials characterised by their function or physical properties
  • A61L 27/54 - Biologically active materials, e.g. therapeutic substances
  • A61K 35/12 - Materials from mammalsCompositions comprising non-specified tissues or cellsCompositions comprising non-embryonic stem cellsGenetically modified cells
  • A61L 27/40 - Composite materials, i.e. layered or containing one material dispersed in a matrix of the same or different material
  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61L 27/26 - Mixtures of macromolecular materials
  • A61K 9/14 - Particulate form, e.g. powders

39.

Variable density tissue graft composition and methods of making and using the same

      
Application Number 14592997
Grant Number 09579183
Status In Force
Filing Date 2015-01-09
First Publication Date 2015-07-16
Grant Date 2017-02-28
Owner ACell, Inc. (USA)
Inventor
  • Bosley, Jr., Rodney W.
  • Fette, Clay

Abstract

Disclosed are tissue graft compositions made of materials having different densities, methods of making, and methods of treatment for restoring tissues in a patient.

IPC Classes  ?

  • A61F 2/02 - Prostheses implantable into the body
  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/50 - Materials characterised by their function or physical properties

40.

Hemostatic device

      
Application Number 14613569
Grant Number 09404077
Status In Force
Filing Date 2015-02-04
First Publication Date 2015-07-16
Grant Date 2016-08-02
Owner ACell, Inc. (USA)
Inventor
  • Fette, Clay
  • Janis, Abram
  • Kibalo, Benjamin

Abstract

A hemostatic device, method of making, and method of using for internal and external applications to wounds in the body of a patient to induce hemostasis at an anatomical site.

IPC Classes  ?

  • C12N 5/00 - Undifferentiated human, animal or plant cells, e.g. cell linesTissuesCultivation or maintenance thereofCulture media therefor
  • C12N 5/02 - Propagation of single cells or cells in suspensionMaintenance thereofCulture media therefor
  • A01N 63/00 - Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
  • A01N 65/00 - Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
  • A61B 17/00 - Surgical instruments, devices or methods
  • A61L 31/00 - Materials for other surgical articles
  • A61L 15/40 - Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/54 - Biologically active materials, e.g. therapeutic substances
  • A61L 27/58 - Materials at least partially resorbable by the body

41.

Hemostatic device

      
Application Number 14508520
Grant Number 08975075
Status In Force
Filing Date 2014-10-07
First Publication Date 2015-02-05
Grant Date 2015-03-10
Owner ACell, Inc. (USA)
Inventor
  • Fette, Clay
  • Janis, Abram
  • Kibalo, Benjamin

Abstract

A hemostatic device, method of making, and method of using for internal and external applications to wounds in the body of a patient to induce hemostasis at an anatomical site.

IPC Classes  ?

  • C12N 5/00 - Undifferentiated human, animal or plant cells, e.g. cell linesTissuesCultivation or maintenance thereofCulture media therefor
  • C12N 5/02 - Propagation of single cells or cells in suspensionMaintenance thereofCulture media therefor
  • A01N 63/00 - Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
  • A01N 65/00 - Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
  • A61F 2/00 - Filters implantable into blood vesselsProstheses, i.e. artificial substitutes or replacements for parts of the bodyAppliances for connecting them with the bodyDevices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
  • A61K 9/14 - Particulate form, e.g. powders
  • A61B 17/08 - Wound clamps
  • A61D 1/00 - Surgical instruments for veterinary use
  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/58 - Materials at least partially resorbable by the body
  • A61L 27/54 - Biologically active materials, e.g. therapeutic substances

42.

Methods of manufacturing bioactive gels from extracellular matrix material

      
Application Number 14332465
Grant Number 09119831
Status In Force
Filing Date 2014-07-16
First Publication Date 2014-11-20
Grant Date 2015-09-01
Owner ACell, Inc. (USA)
Inventor
  • Kentner, Kimberly A.
  • Stuart, Katherine A.
  • Janis, Abram D.

Abstract

The present invention is directed to methods of manufacturing bioactive gels from ECM material, i.e., gels which retain bioactivity, and can serve as scaffolds for preclinical and clinical tissue engineering and regenerative medicine approaches to tissue reconstruction. The manufacturing methods take advantage of a new recognition that bioactive gels from ECM material can be created by digesting particularized ECM material in an alkaline environment and neutralizing to provide bioactive gels.

IPC Classes  ?

  • C12N 5/00 - Undifferentiated human, animal or plant cells, e.g. cell linesTissuesCultivation or maintenance thereofCulture media therefor
  • C12N 5/02 - Propagation of single cells or cells in suspensionMaintenance thereofCulture media therefor
  • A61K 35/37 - Digestive system
  • A61K 35/38 - StomachIntestineGoblet cellsOral mucosaSaliva
  • A61K 35/407 - LiverHepatocytes
  • A61K 35/22 - UrineUrinary tract, e.g. kidney or bladderIntraglomerular mesangial cellsRenal mesenchymal cellsAdrenal gland
  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/52 - Hydrogels or hydrocolloids
  • A61L 27/54 - Biologically active materials, e.g. therapeutic substances
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 35/12 - Materials from mammalsCompositions comprising non-specified tissues or cellsCompositions comprising non-embryonic stem cellsGenetically modified cells
  • A61K 38/18 - Growth factorsGrowth regulators

43.

METHODS OF MANUFACTURING BIOACTIVE GELS FROM EXTRACELLULAR MATRIX MATERIAL

      
Application Number US2014015214
Publication Number 2014/124203
Status In Force
Filing Date 2014-02-07
Publication Date 2014-08-14
Owner ACELL, INC. (USA)
Inventor
  • Kentner, Kimberly, A.
  • Stuart, Katherine, A.
  • Janis, Abram, D.

Abstract

The present invention is directed to methods of manufacturing bioactive gels from ECM material, i.e., gels which retain bioactivity, and can serve as scaffolds for preclinical and clinical tissue engineering and regenerative medicine approaches to tissue reconstruction. The manufacturing methods take advantage of a new recognition that bioactive gels from ECM material can be created by digesting particularized ECM material in an alkaline environment and neutralizing to provide bioactive gels.

IPC Classes  ?

  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/52 - Hydrogels or hydrocolloids
  • A61L 27/54 - Biologically active materials, e.g. therapeutic substances

44.

Methods of manufacturing bioactive gels from extracellular matrix material

      
Application Number 14174980
Grant Number 08802436
Status In Force
Filing Date 2014-02-07
First Publication Date 2014-08-12
Grant Date 2014-08-12
Owner ACell, Inc. (USA)
Inventor
  • Kentner, Kimberly A.
  • Stuart, Katherine A.
  • Janis, Abram D.

Abstract

The present invention is directed to methods of manufacturing bioactive gels from ECM material, i.e., gels which retain bioactivity, and can serve as scaffolds for preclinical and clinical tissue engineering and regenerative medicine approaches to tissue reconstruction. The manufacturing methods take advantage of a new recognition that bioactive gels from ECM material can be created by digesting particularized ECM material in an alkaline environment and neutralizing to provide bioactive gels.

IPC Classes  ?

  • C12N 5/00 - Undifferentiated human, animal or plant cells, e.g. cell linesTissuesCultivation or maintenance thereofCulture media therefor
  • C12N 5/02 - Propagation of single cells or cells in suspensionMaintenance thereofCulture media therefor
  • A61K 35/37 - Digestive system
  • A61K 35/38 - StomachIntestineGoblet cellsOral mucosaSaliva
  • A61K 35/407 - LiverHepatocytes

45.

Particulate tissue graft with components of differing density and methods of making and using the same

      
Application Number 14163046
Grant Number 09056078
Status In Force
Filing Date 2014-01-24
First Publication Date 2014-05-22
Grant Date 2015-06-16
Owner ACell, Inc. (USA)
Inventor
  • Bosley, Jr., Rodney W.
  • Fette, Clay
  • Tullius, Robert S.

Abstract

Disclosed are tissue graft compositions made of particles having different densities, methods of making these compositions, and methods of using these compositions for promoting tissue restoration in a patient.

IPC Classes  ?

  • A61K 35/12 - Materials from mammalsCompositions comprising non-specified tissues or cellsCompositions comprising non-embryonic stem cellsGenetically modified cells
  • A61L 27/26 - Mixtures of macromolecular materials
  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/58 - Materials at least partially resorbable by the body

46.

Hemostatic device

      
Application Number 14161826
Grant Number 08835174
Status In Force
Filing Date 2014-01-23
First Publication Date 2014-05-15
Grant Date 2014-09-16
Owner ACell, Inc. (USA)
Inventor
  • Fette, Clay
  • Janis, Abram
  • Kibalo, Benjamin

Abstract

A hemostatic device, method of making, and method of using for internal and external applications to wounds in the body of a patient to induce hemostasis at an anatomical site.

IPC Classes  ?

  • C12N 5/00 - Undifferentiated human, animal or plant cells, e.g. cell linesTissuesCultivation or maintenance thereofCulture media therefor
  • C12N 5/02 - Propagation of single cells or cells in suspensionMaintenance thereofCulture media therefor
  • A01N 63/00 - Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
  • A01N 65/00 - Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
  • A61F 2/00 - Filters implantable into blood vesselsProstheses, i.e. artificial substitutes or replacements for parts of the bodyAppliances for connecting them with the bodyDevices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
  • A61K 9/14 - Particulate form, e.g. powders
  • A61B 17/08 - Wound clamps
  • A61D 1/00 - Surgical instruments for veterinary use
  • A61B 17/00 - Surgical instruments, devices or methods

47.

Variable density tissue graft composition and methods of making and using the same

      
Application Number 14031855
Grant Number 08962035
Status In Force
Filing Date 2013-09-19
First Publication Date 2014-01-16
Grant Date 2015-02-24
Owner ACell, Inc. (USA)
Inventor
  • Bosley, Jr., Rodney W.
  • Fette, Clay

Abstract

Disclosed are tissue graft compositions made of materials having different densities, methods of making, and methods of treatment for restoring tissues in a patient.

IPC Classes  ?

  • A61K 35/12 - Materials from mammalsCompositions comprising non-specified tissues or cellsCompositions comprising non-embryonic stem cellsGenetically modified cells
  • A61K 35/32 - BonesOsteocytesOsteoblastsTendonsTenocytesTeethOdontoblastsCartilageChondrocytesSynovial membrane
  • A61F 2/02 - Prostheses implantable into the body
  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/50 - Materials characterised by their function or physical properties

48.

Hemostatic device

      
Application Number 13706987
Grant Number 08895304
Status In Force
Filing Date 2012-12-06
First Publication Date 2013-06-13
Grant Date 2014-11-25
Owner ACell, Inc. (USA)
Inventor
  • Fette, Clay
  • Janis, Abram
  • Kibalo, Benjamin

Abstract

A hemostatic device, method of making, and method of using for internal and external applications to wounds in the body of a patient to induce hemostasis at an anatomical site.

IPC Classes  ?

  • C12N 5/00 - Undifferentiated human, animal or plant cells, e.g. cell linesTissuesCultivation or maintenance thereofCulture media therefor
  • C12N 5/02 - Propagation of single cells or cells in suspensionMaintenance thereofCulture media therefor
  • A01N 63/00 - Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
  • A01N 65/00 - Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
  • A61F 2/00 - Filters implantable into blood vesselsProstheses, i.e. artificial substitutes or replacements for parts of the bodyAppliances for connecting them with the bodyDevices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
  • A61K 9/14 - Particulate form, e.g. powders
  • A61B 17/08 - Wound clamps
  • A61D 1/00 - Surgical instruments for veterinary use
  • A61L 15/40 - Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof
  • A61L 31/00 - Materials for other surgical articles
  • A61B 17/00 - Surgical instruments, devices or methods

49.

HEMOSTATIC DEVICE

      
Application Number US2012068193
Publication Number 2013/086153
Status In Force
Filing Date 2012-12-06
Publication Date 2013-06-13
Owner ACELL, INC. (USA)
Inventor
  • Fette, Clay
  • Janis, Abram
  • Kibalo, Benjamin

Abstract

A hemostatic device, method of making, and method of using for internal and external applications to wounds in the body of a patient to induce hemostasis at an anatomical site.

IPC Classes  ?

  • A61L 15/40 - Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof
  • A61L 31/00 - Materials for other surgical articles

50.

Particulate tissue graft with components of differing density and methods of making and using the same

      
Application Number 13681610
Grant Number 08968761
Status In Force
Filing Date 2012-11-20
First Publication Date 2013-05-09
Grant Date 2015-03-03
Owner ACell, Inc. (USA)
Inventor
  • Bosley, Jr., Rodney W.
  • Fette, Clay
  • Tullius, Robert S.

Abstract

Disclosed are tissue graft compositions made of particles having different densities, methods of making these compositions, and methods of using these compositions for promoting tissue restoration in a patient.

IPC Classes  ?

  • A61F 13/00 - Bandages or dressingsAbsorbent pads
  • A61F 2/00 - Filters implantable into blood vesselsProstheses, i.e. artificial substitutes or replacements for parts of the bodyAppliances for connecting them with the bodyDevices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
  • A61K 35/12 - Materials from mammalsCompositions comprising non-specified tissues or cellsCompositions comprising non-embryonic stem cellsGenetically modified cells
  • A61L 27/26 - Mixtures of macromolecular materials
  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/58 - Materials at least partially resorbable by the body

51.

Tissue graft composition

      
Application Number 13649522
Grant Number 08541032
Status In Force
Filing Date 2012-10-11
First Publication Date 2013-02-07
Grant Date 2013-09-24
Owner ACell, Inc. (USA)
Inventor
  • Bosley, Jr., Rodney W.
  • Fette, Clay

Abstract

Disclosed are tissue graft compositions made of materials having different densities, methods of making, and methods of treatment for restoring tissues in a patient.

IPC Classes  ?

  • A61K 35/12 - Materials from mammalsCompositions comprising non-specified tissues or cellsCompositions comprising non-embryonic stem cellsGenetically modified cells
  • A61K 35/32 - BonesOsteocytesOsteoblastsTendonsTenocytesTeethOdontoblastsCartilageChondrocytesSynovial membrane

52.

MICROMATRIX

      
Serial Number 85317666
Status Registered
Filing Date 2011-05-11
Registration Date 2013-05-28
Owner ACell, Inc. ()
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

Scaffold composed of biological tissue in powdered form for medical use; naturally occurring bio-scaffold in powdered form for repair or restoration of tissue in a patient Scaffold composed of non-living material in powdered form for repair or restoration of tissue in a patient

53.

PARTICULATE TISSUE GRAFT WITH COMPONENTS OF DIFFERING DENSITY AND METHODS OF MAKING AND USING THE SAME

      
Document Number 02768727
Status In Force
Filing Date 2010-07-21
Open to Public Date 2011-01-27
Grant Date 2018-01-16
Owner ACELL, INC. (USA)
Inventor
  • Bosley, Rodney W., Jr.
  • Fette, Clay
  • Tullius, Robert S.

Abstract

Disclosed are tissue graft compositions made of particles having different densities, methods of making these compositions, and methods of using these compositions for promoting tissue restoration in a patient.

IPC Classes  ?

  • A61L 27/14 - Macromolecular materials
  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/58 - Materials at least partially resorbable by the body

54.

PARTICULATE TISSUE GRAFT WITH COMPONENTS OF DIFFERING DENSITY AND METHODS OF MAKING AND USING THE SAME

      
Document Number 02986673
Status In Force
Filing Date 2010-07-21
Open to Public Date 2011-01-27
Grant Date 2021-08-17
Owner ACELL, INC. (USA)
Inventor
  • Bosley, Rodney W., Jr
  • Fette, Clay
  • Tullius, Robert S.

Abstract

An implant for implanting at the site of an anatomical tissue in a human patient, comprises a plurality of bioresorbable composite particles, each of said composite particles comprising a portion derived from each of two extracellular matrix materials, wherein one of said two extracellular matrix materials comprises a density that is greater than the density of the other of said two extracellular matrix materials.

IPC Classes  ?

  • A61L 27/58 - Materials at least partially resorbable by the body

55.

Particulate tissue graft with components of differing density and methods of making and using the same

      
Application Number 12507311
Grant Number 08652500
Status In Force
Filing Date 2009-07-22
First Publication Date 2011-01-27
Grant Date 2014-02-18
Owner Acell, Inc. (USA)
Inventor
  • Bosley, Jr., Rodney W.
  • Fette, Clay
  • Tullius, Robert S.

Abstract

Disclosed are tissue graft compositions made of particles having different densities, methods of making these compositions, and methods of using these compositions for promoting tissue restoration in a patient.

IPC Classes  ?

  • A61F 13/00 - Bandages or dressingsAbsorbent pads
  • A61F 2/00 - Filters implantable into blood vesselsProstheses, i.e. artificial substitutes or replacements for parts of the bodyAppliances for connecting them with the bodyDevices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents

56.

Variable density tissue graft composition

      
Application Number 12507338
Grant Number 08298586
Status In Force
Filing Date 2009-07-22
First Publication Date 2011-01-27
Grant Date 2012-10-30
Owner Acell Inc (USA)
Inventor
  • Bosley, Jr., Rodney W.
  • Fette, Clay

Abstract

Disclosed are tissue graft compositions made of materials having different densities, methods of making, and methods of treatment for restoring tissues in a patient.

IPC Classes  ?

  • A61K 35/12 - Materials from mammalsCompositions comprising non-specified tissues or cellsCompositions comprising non-embryonic stem cellsGenetically modified cells
  • A61K 35/32 - BonesOsteocytesOsteoblastsTendonsTenocytesTeethOdontoblastsCartilageChondrocytesSynovial membrane

57.

VARIABLE DENSITY TISSUE GRAFT COMPOSITION AND METHODS OF MAKING AND USING THE SAME

      
Application Number US2010042698
Publication Number 2011/011482
Status In Force
Filing Date 2010-07-21
Publication Date 2011-01-27
Owner ACELL, INC. (USA)
Inventor
  • Bosley, Rodney, W., Jr.
  • Fette, Clay

Abstract

Disclosed are tissue graft compositions made of materials having different densities, methods of making, and methods of treatment for restoring tissues in a patient.

IPC Classes  ?

  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/50 - Materials characterised by their function or physical properties

58.

PARTICULATE TISSUE GRAFT WITH COMPONENTS OF DIFFERING DENSITY AND METHODS OF MAKING AND USING THE SAME

      
Application Number US2010042701
Publication Number 2011/011484
Status In Force
Filing Date 2010-07-21
Publication Date 2011-01-27
Owner ACELL, INC. (USA)
Inventor
  • Bosley, Jr., Rodney, W.
  • Fette, Clay
  • Tullius, Robert, S.

Abstract

Disclosed are tissue graft compositions made of particles having different densities, methods of making these compositions, and methods of using these compositions for promoting tissue restoration in a patient.

IPC Classes  ?

  • A61L 27/14 - Macromolecular materials
  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
  • A61L 27/58 - Materials at least partially resorbable by the body

59.

MATRISTEM

      
Application Number 149656500
Status Registered
Filing Date 2010-09-20
Registration Date 2014-09-19
Owner ACell, Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

(1) Scaffold composed of biological tissue, namely, naturally occurring bio-scaffold for repair or restoration of tissue in a patient. (2) Scaffold comprised of synthetic matter for repair or restoration of tissue in a patient.

60.

MATRISTEM

      
Application Number 009381443
Status Registered
Filing Date 2010-09-16
Registration Date 2014-02-08
Owner Acell, Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Scaffold composed of biological tissue, namely, naturally occurring bio-scaffold for repair or restoration of tissue in a patient; Surgical tissues. Scaffold comprised of synthetic matter for repair or restoration of tissue in a patient; Surgical, medical and veterinary apparatus and instruments; orthopedic articles; suture materials; artificial skin for surgical purposes. Medical services; Veterinary services; Hygienic and beauty care for human beings or animals.

61.

ACELL

      
Application Number 149471500
Status Registered
Filing Date 2010-09-03
Registration Date 2012-05-31
Owner ACell, Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

(1) Pharmaceutical and veterinary preparations of biological origin, for tissue reconstruction; surgical implants; dressings; surgical tissues; scaffold material for medical use and for repair or restoration of tissue. (2) Surgical, medical and veterinary apparatus and instruments namely, extracellular matrix ("ECM") devices to repair and remodel damaged tissues and organs; artificial skin for surgical purposes; scaffold material for repair or restoration of tissue; scaffold composed of non-living implants for repair and restoration of tissue

62.

ACELL VET

      
Serial Number 85039074
Status Registered
Filing Date 2010-05-14
Registration Date 2011-01-04
Owner Acell, Inc. ()
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

Scaffold composed of biological tissue for medical use, namely, naturally occurring bio-scaffold for repair or restoration of tissue for veterinary use Scaffold material composed of non-living implants for repair or restoration of tissue for veterinary use

63.

MatriStem

      
Application Number 008302333
Status Registered
Filing Date 2009-05-14
Registration Date 2010-07-22
Owner Acell, Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.

64.

MATRISTEM

      
Serial Number 77526850
Status Registered
Filing Date 2008-07-21
Registration Date 2009-06-02
Owner ACell, Inc. ()
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

SCAFFOLD COMPOSED OF BIOLOGICAL TISSUE, NAMELY, NATURALLY OCCURRING BIO-SCAFFOLD FOR REPAIR OR RESTORATION OF TISSUE IN A PATIENT SCAFFOLD COMPRISED OF SYNTHETIC MATTER FOR REPAIR OR RESTORATION OF TISSUE IN A PATIENT

65.

ACell

      
Application Number 004188116
Status Registered
Filing Date 2004-12-13
Registration Date 2007-01-26
Owner Acell, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical and veterinary preparations of biological origin, for tissue reconstruction; surgical implants (Class 5).

66.

ACELL

      
Serial Number 78155781
Status Registered
Filing Date 2002-08-20
Registration Date 2004-11-02
Owner Acell, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

scaffold material composed of biological tissue, namely, naturally occurring bio-scaffold material derived from porcine bladders for repair or restoration of tissue in a patient, none of the foregoing for orthopedic, cranio-facial, maxillary, and dental applications in the human field

67.

ACELL

      
Serial Number 78155813
Status Registered
Filing Date 2002-08-20
Registration Date 2004-11-02
Owner Acell, Inc. ()
NICE Classes  ? 10 - Medical apparatus and instruments

Goods & Services

Scaffold material composed of non-living implants for repair or restoration of tissue in a patient, none of the foregoing for orthopedic, cranio-facial, maxillary, and dental applications in the human field